New 52 Week Low Today

Plus Therapeutics Inc PSTV:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 10/22/21 EDT
1.66quote price arrow up+0.01 (+0.61%)
Volume
1,371
Close
1.65quote price arrow down-0.08 (-4.62%)
Volume
335,722
52 week range
1.59 - 5.42
Loading...
  • Open1.70
  • Day High1.70
  • Day Low1.59
  • Prev Close1.73
  • 52 Week High5.42
  • 52 Week High Date02/10/21
  • 52 Week Low1.59
  • 52 Week Low Date10/22/21

Key Stats

  • Market Cap25.26M
  • Shares Out15.31M
  • 10 Day Average Volume0.21M
  • Dividend-
  • Dividend Yield-
  • Beta0.33
  • YTD % Change-18.32

KEY STATS

  • Open1.70
  • Day High1.70
  • Day Low1.59
  • Prev Close1.73
  • 52 Week High5.42
  • 52 Week High Date02/10/21
  • 52 Week Low1.59
  • 52 Week Low Date10/22/21
  • Market Cap25.26M
  • Shares Out15.31M
  • 10 Day Average Volume0.21M
  • Dividend-
  • Dividend Yield-
  • Beta0.33
  • YTD % Change-18.32

RATIOS/PROFITABILITY

  • EPS (TTM)-1.53
  • P/E (TTM)-1.08
  • Fwd P/E (NTM)-1.64
  • EBITDA (TTM)-9.488M
  • ROE (TTM)-142.15%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)20.13%
  • Net Margin (TTM)-5,337.30%
  • Debt To Equity (MRQ)55.40%

EVENTS

  • Earnings Date02/21/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Plus Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Plus Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on developing treatments for patients battling cancer. The Company provides nanotechnology platform to reformulate and improve workhorse chemotherapeutics to provide benefits to patients and healthcare providers. The Company is focused on developing generic oncology drugs that address unmet medical and market needs. The Company’s lead product candidate, DocePLUS, is an...
Richard Hawkins
Chairman
Marc Hedrick M.D.
Chief Executive Officer
Steven Kesten M.D.
President
Andrew Sims CPA
Chief Financial Officer
Desiree Smith CPA
Chief Accounting Officer
Address
4200 Marathon Blvd Ste 200
Austin, TX
78756-3433
United States

Top Peers

SYMBOLLASTCHG%CHG
ATXI
Avenue Therapeutics Inc
1.26-0.07-5.26%
PBLA
Panbela Therapeutics Inc
2.03-0.08-3.79%
PHIO
Phio Pharmaceuticals Corp
1.63-0.08-4.68%
FWBI
First Wave BioPharma Inc
2.71-0.25-8.45%
ARTL
Artelo Biosciences Inc
0.7399-0.01-1.3335%